BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $235,909 | +12.3% | 5,178 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $210,019 | -20.4% | 5,178 | 0.0% | 0.01% | -33.3% |
| Q4 2022 | $263,922 | -28.5% | 5,178 | -24.4% | 0.01% | -35.7% |
| Q3 2022 | $369,000 | -16.1% | 6,848 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $440,000 | -4.6% | 6,848 | +15.1% | 0.02% | +6.7% |
| Q1 2022 | $461,000 | -12.4% | 5,948 | -3.0% | 0.02% | -11.8% |
| Q4 2021 | $526,000 | +3.5% | 6,134 | -2.8% | 0.02% | -15.0% |
| Q3 2021 | $508,000 | -7.3% | 6,309 | -7.3% | 0.02% | -4.8% |
| Q2 2021 | $548,000 | -7.9% | 6,809 | -3.5% | 0.02% | -19.2% |
| Q1 2021 | $595,000 | +4.0% | 7,055 | -0.9% | 0.03% | -3.7% |
| Q4 2020 | $572,000 | -0.2% | 7,119 | 0.0% | 0.03% | -10.0% |
| Q3 2020 | $573,000 | -30.0% | 7,119 | -25.2% | 0.03% | -36.2% |
| Q2 2020 | $819,000 | +11.6% | 9,520 | +5.4% | 0.05% | -7.8% |
| Q1 2020 | $734,000 | +73.1% | 9,036 | +78.4% | 0.05% | +112.5% |
| Q4 2019 | $424,000 | -8.0% | 5,066 | -3.7% | 0.02% | -14.3% |
| Q3 2019 | $461,000 | +7.0% | 5,262 | 0.0% | 0.03% | +3.7% |
| Q2 2019 | $431,000 | +0.7% | 5,262 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $428,000 | +27.0% | 5,262 | +3.0% | 0.03% | +8.0% |
| Q4 2018 | $337,000 | -14.5% | 5,109 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $394,000 | +18.7% | 5,109 | 0.0% | 0.02% | +8.7% |
| Q1 2018 | $332,000 | +4.4% | 5,109 | +3.7% | 0.02% | +4.5% |
| Q4 2017 | $318,000 | +2.6% | 4,929 | 0.0% | 0.02% | -4.3% |
| Q3 2017 | $310,000 | +4.0% | 4,929 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $298,000 | +16.4% | 4,929 | 0.0% | 0.02% | +15.0% |
| Q1 2017 | $256,000 | +16.9% | 4,929 | 0.0% | 0.02% | +11.1% |
| Q4 2016 | $219,000 | -42.2% | 4,929 | -4.5% | 0.02% | -55.0% |
| Q4 2014 | $379,000 | -16.9% | 5,162 | -21.2% | 0.04% | -23.1% |
| Q4 2013 | $456,000 | +4.3% | 6,548 | 0.0% | 0.05% | -20.0% |
| Q4 2012 | $437,000 | +34.0% | 6,548 | -0.5% | 0.06% | +18.2% |
| Q4 2011 | $326,000 | -19.9% | 6,583 | -18.1% | 0.06% | -21.4% |
| Q4 2010 | $407,000 | +9.4% | 8,039 | +26.8% | 0.07% | -1.4% |
| Q4 2009 | $372,000 | +34.8% | 6,339 | +23.2% | 0.07% | +6.0% |
| Q4 2008 | $276,000 | – | 5,145 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |